Leaderboards/colorectal and anal carcinomas

colorectal and anal carcinomas

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Aurélien Marabelle
Institut Gustave Roussy
80
2
Gbaa LZ
Benue State University
70
3
Obunadike CB
Benue State University
60
4
Jarosław Cwaliński
Poznan University of Medical Sciences
50
5
Jacek Paszkowski
Poznan University of Medical Sciences
40
6
Yasuhide Muto
Social Welfare Organization Saiseikai Imperial Gift Foundation
30
7
Michio Itabashi
Social Welfare Organization Saiseikai Imperial Gift Foundation
20
8
Monika Vyas
Hadassah Medical Center
10

Rising Stars Papers

1
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers
Cell Reports Medicine|2025
5 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jian‐Xuan Sun
Tongji Hospital
99
2
Brinda Gupta
Georgetown University
90
3
F. Verdasca
Administração Regional de Saúde de Lisboa e Vale do Tejo
70
4
Khadija Soufi
University of California Davis Medical Center
60
5
Matthias Kraemer
University of Münster
50
6
Kilian G. M. Brown
The University of Sydney
40
7
Ryan J. Sullivan
Massachusetts General Hospital
30
8
Ahmed Farag
Cairo University
20
9
Alexis Weston
Translational Genomics Research Institute
10

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Dirk Arnold
University Medical Center Freiburg
99
2
Angela Balkwill
University of Oxford
90
3
Markus F. Neurath
Johannes Gutenberg University Mainz
80
4
Arnold Wald
University of Wisconsin–Madison
70
5
Thomas Kirchner
Friedrich-Alexander-Universität Erlangen-Nürnberg
60
6
William J. Sandborn
Mayo Clinic
50
7
W. Douglas Wong
Memorial Sloan Kettering Cancer Center
40
8
Shinichi Watanabe
Teikyo University
30
9
Raymond N. DuBois
Vanderbilt University Medical Center
20
10
Frank Hoentjen
Radboud University Nijmegen
10

All-Time Leaders Papers

1
Crohn's disease
The Lancet|2012
2.1k cit.
2
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Clinical Gastroenterology and Hepatology|2006
906 cit.
3
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
Annals of Oncology|2017
829 cit.
4
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
Journal of Clinical Investigation|2003
803 cit.
5
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
New England Journal of Medicine|2012
794 cit.
6
β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
American Journal Of Pathology|1999
663 cit.
7
Chromoscopy-Guided Endomicroscopy Increases the Diagnostic Yield of Intraepithelial Neoplasia in Ulcerative Colitis
Gastroenterology|2007
530 cit.
8
Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor
Journal of Biological Chemistry|2003
463 cit.
9
RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
Gastroenterology|2008
449 cit.
10
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer
The Journal of Experimental Medicine|2010
170 cit.

Indexing colorectal and anal carcinomas Reagents

Citation data for reagents in this field is currently compiling.